ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

Missouri Center Director Search Narrowed To Vincent, Wiernik

September 10, 1982

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

In Brief: Elizabeth Miller Dies; Mihich Names Associate Director At RPMI; AACR Calls For Abstracts

October 23, 1987

With a “B” from USPSTF, Low-Dose CT Screening For Lung Cancer Earns Coverage Under ACA

August 2, 2013

Breast Cancer Strategic Plan Underway Following HHS Secretary’s Conference

January 7, 1994

Clinton Names Broadnax HHS Deputy, Others to Sub-Cabinet Posts

March 5, 1993